Cita APA

Bono, P., Massard, C., Peltola, K. J., Azaro Pedrazzoli, A. B., Kristeleit, R. S., Rodon Ahnert, J., & Italiano, A. (2020). Phase I/IIa, open-label, multicentre study to evaluate the optimal dosing and safety of ODM-203 in patients with advanced or metastatic solid tumours.

Citación estilo Chicago

Bono, Petri, Christophe Massard, Katriina J. Peltola, Analía Beatriz Azaro Pedrazzoli, Rebecca S. Kristeleit, Jordi Rodon Ahnert, y Antoine Italiano. Phase I/IIa, Open-label, Multicentre Study to Evaluate the Optimal Dosing and Safety of ODM-203 in Patients With Advanced or Metastatic Solid Tumours. 2020.

Cita MLA

Bono, Petri, et al. Phase I/IIa, Open-label, Multicentre Study to Evaluate the Optimal Dosing and Safety of ODM-203 in Patients With Advanced or Metastatic Solid Tumours. 2020.